You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Bioactive Polymer Designed for Cardiac Assist Devices
SBC: ABIOMED, INC. Topic: N/ADESCRIPTION (provided by applicant): The ultimate objective of this proposal is the development of a novel, bioactive polymer for use in ventricular assist devices (VAD), and other long-term blood contacting implantable devices. Although VADs are becoming an important therapeutic option for patients in heart failure, serious problems persist secondary to thromboembolic complications and continue t ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
An Artificial Myocardium for Pediatric Support
SBC: ABIOMED, INC. Topic: N/ADESCRIPTION (provided by applicant): The ultimate objective of this proposal is the commercialization of a pediatric ventricular assist device (VAD). Although, VADs, both implantable and paracorporeal, have become an important surgical option for adult patients with myocardial failure unresponsive to less aggressive therapy, no VADs are commercially available for short-term use in children or smal ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Brain Trauma Assessment System
SBC: Active Signal Technologies, Inc. Topic: N/ADESCRIPTION (provided by applicant): With over 1.5 million persons suffering head injury annually in the U.S., and approximately 50,000 dying from these injuries, a need exists for early direct assessment of brain injury. Currently, injuries must be inferred from Glascow Coma Scores (GCS), low blood pressure, and/or low pulse oximetry, but there is no direct method of measuring brain condition at ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
New Agents That Inhibit Fatty Acid Accumulation
SBC: ADIPOGENIX, INC. Topic: N/ADESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. Although weight loss is the most effective treatment for type 2 diabetes, current methods for reducing weight typically are insufficient for long-term weight loss. The mission of AdipoGenix, Inc. is to discover, develop and license novel the ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Activators of Adipocyte Fatty Acid Oxidation
SBC: ADIPOGENIX, INC. Topic: N/ADESCRIPTION (provided by applicant): Obesity is a well-established risk factor for a number of diseases, including type 2 diabetes and coronary heart disease. Existing drug and dietary treatments for obesity are only modestly effective. An approach that is very likely to be effective in treating obesity and with a good side effect profile is a drug that acts directly on lipid metabolism in the fat ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
N/A
SBC: 20 20 Genesystems Inc Topic: N/AN/A
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Combination of GM-CSF with TKR gene therapy
SBC: ADVANTAGENE, INC Topic: N/ADESCRIPTION (provided by applicant): Combined gene therapy (Herpes Simplex Virus Thymidine Kinase + Anti-herpetic Prodrug) and radiation therapy (TKR therapy) is a novel approach in the armamentarium against cancer. This radio-gene therapy combination creates a new spatial co-operation whereby two local treatment modalities have demonstrated enhanced local and metastatic tumor control and prolong ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Biothreat Detection with Improved Background Rejection
SBC: AERODYNE RESEARCH INC Topic: N/ADESCRIPTION (provided by applicant): The Quartz Crystal Microbalance (QCM) is a well-established technology for quantifying small changes in mass. The long-term objective of this program is to improve the QCM so that it is suitable for use as a field test for the common, foodborne bacteria. To do this, we will modify the standard quartz crystal (QC) used in the QCM so as to increase its background ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Multiplex polony genotyping
SBC: AGENCOURT BIOSCIENCE CORPORATION Topic: N/A(Revised Abstract) Description: The ascertainment of millions of SNPs in the human genome, characterization of haplotype blocks and development of improved SNP-based linkage panels has fueled the need for accurate, efficient, and low cost SNP genotyping technologies to support genetic inheritance and disease association studies. The overall goals of this proposal are to develop and test a novel m ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health -
Cellular Microarrays for in vitro toxicology screens
SBC: AKCELI, INC. Topic: N/ADESCRIPTION (provided by applicant): The studies outlined in this proposal are the first steps towards the establishment of a high throughput in vitro toxicology screen using mammalian cells. Toxicological screens are a critical component of the drug discovery process but are often employed late in the process due to the constraints of cost and throughput. The enablement of valid toxicology scr ...
SBIR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health